A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS)

Summary

This study will test the hypothesis that GW427353, a beta-3 adrenergic agonist, will relieve IBS pain or discomfort and associated symptoms in IBS patients.

Timeline

Start

2006-08

Primary completion

—

Completion

—

Drugs

Indications